New drug targets dangerous fat levels in blood
NCT ID NCT03783377
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new medicine called ARO-APOC3 in healthy volunteers and people with severely high triglycerides or a rare genetic condition called familial chylomicronemia syndrome. The main goal was to check safety and how the drug moves through the body. The study involved 112 participants and has been completed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 10
Papatoetoe, Auckland, 2025, New Zealand
-
Research Site 11
Christchurch, 8011, New Zealand
-
Research Site 2
Camperdown, New South Wales, 2050, Australia
-
Research Site 3
Adelaide, South Australia, 5000, Australia
-
Research Site 4
Perth, Washington, 6009, Australia
-
Research Site 5
Sippy Downs, Queensland, Australia
-
Research Site 6
Chicoutimi, Quebec, G7H 7K9, Canada
-
Research Site 7
London, Ontario, N6A 5B7, Canada
-
Research Site 8
Montreal, Quebec, H2W 1R7, Canada
-
Research Site 9
Grafton, Auckland, 1010, New Zealand